|
SFRS13B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.46450000004794E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65889999959035E-07 |
| Normal-vs-Stage2 |
1.530750E-01 |
| Normal-vs-Stage3 |
2.137600E-02 |
| Normal-vs-Stage4 |
5.103900E-02 |
| Stage1-vs-Stage2 |
1.610830E-01 |
| Stage1-vs-Stage3 |
2.661900E-02 |
| Stage1-vs-Stage4 |
1.955630E-01 |
| Stage2-vs-Stage3 |
9.767600E-01 |
| Stage2-vs-Stage4 |
8.185000E-01 |
| Stage3-vs-Stage4 |
7.382800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.59519999995717E-06 |
| Normal-vs-AfricanAmerican |
9.047600E-02 |
| Normal-vs-Asian |
1.085600E-01 |
| Caucasian-vs-AfricanAmerican |
8.965000E-01 |
| Caucasian-vs-Asian |
2.547000E-01 |
| AfricanAmerican-vs-Asian |
2.534400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.197800E-04 |
| Normal-vs-Female |
1.5594299999977E-05 |
| Male-vs-Female |
2.557800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.573800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.226620E-04 |
| Normal-vs-Age(61-80Yrs) |
7.54310000000702E-05 |
| Normal-vs-Age(81-100Yrs) |
2.596000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.626200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.300600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.753400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.177600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.446800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.697600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.790780E-01 |
| Normal-vs-Grade 2 |
9.23099999772248E-08 |
| Normal-vs-Grade 3 |
4.761700E-04 |
| Normal-vs-Grade 4 |
9.873800E-01 |
| Grade 1-vs-Grade 2 |
4.919400E-01 |
| Grade 1-vs-Grade 3 |
7.237000E-01 |
| Grade 1-vs-Grade 4 |
2.036400E-01 |
| Grade 2-vs-Grade 3 |
2.588400E-01 |
| Grade 2-vs-Grade 4 |
3.50570000000605E-05 |
| Grade 3-vs-Grade 4 |
3.660900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.22669999000647E-09 |
| Normal-vs-ccB subtype |
3.995700E-02 |
| ccA subtype-vs-ccB subtype |
3.759000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.598860E-04 |
| Normal-vs-N1 |
8.028800E-01 |
| N0-vs-N1 |
8.021800E-02 |
|
|
